Oral Anti-Diabetic Agents
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
ROSIGLITAZONE: products 1 to 6 of 6.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Avandia 2mg TabDIN 02241112 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Avandia 4mg TabDIN 02241113 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Avandia 8mg TabDIN 02241114 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Rosiglitazone 2mg TabDIN 02403366 | Off-Formulary Interchangeable, not an ODB benefit | $1.2234per source unit | Requirements & sourcesBuild cost plan |
| Rosiglitazone 4mg TabDIN 02403374 | Off-Formulary Interchangeable, not an ODB benefit | $1.9197per source unit | Requirements & sourcesBuild cost plan |
| Rosiglitazone 8mg TabDIN 02403382 | Off-Formulary Interchangeable, not an ODB benefit | $2.7452per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
68:20:02 Oral Anti-Diabetic Agents.